Vascular endothelial growth factor expression and neovascularization in non-small cell lung carcinoma

International Journal of Surgical Pathology

Volumn 17, Issue 5, 2009, Pages 390-395

  Ozbudak, Irem Hicran ^a   Ozbilim, Gulay ^a   Kucukosmanoglu, Ilknur ^b   Dertsiz, Levent ^a   Demircan, Abid ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b Erzurum Numune Hastanesi   (Turkey)

Author keywords

Angiogenesis; Non small cell lung carcinoma; Vascular endothelial growth factor; VEGF

Indexed keywords

BLOOD CLOTTING FACTOR 8; VASCULOTROPIN;

ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MICROVASCULARIZATION; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FACTOR VIII; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG; LUNG NEOPLASMS; MALE; MICROCIRCULATION; MICROVESSELS; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349554296     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1066896908323506     Document Type: Article

References (27)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent ? J Natl Cancer Inst. 1990 ; 82: 4-6.
2. Bergers G., Benjamin LE Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003 ; 3: 401-410.
3. Papetti M., Herman IM Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol. 2002 ; 282: C947 - C970.
4. Weidner N., Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991 ; 324: 1-8.
5. Giatromanolaki A., Koukourakis M., O'Byrne K., et al. Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol. 1996 ; 179: 80-88. (Pubitemid 26180086)
6. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997 ; 18: 4-25.
7. Ferrara N., Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003 ; 9: 669-676.
8. Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist. 2000 ; 5 (suppl 1). 37-44.
9. Ueda M., Terai Y., Kanda K., et al. Tumor angiogenesis and molecular target therapy in ovarian carcinomas. Hum Cell. 2005 ; 18: 1-16.
10. Arii S., Mori A., Uchida S., Fujimoto K., Shimada Y., Imamura M. Implication of vascular endothelial growth factor in the development and metastasis of human cancers. Hum Cell. 1999 ; 12: 25-30.
11. O'Byrne KJ, Koukourakis MI, Giatromanolaki A., et al. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br J Cancer. 2000 ; 82: 1427-1432. (Pubitemid 30175909)
12. Giatromanolaki A., Koukourakis MI, Sivridis E., O'Byrne K., Gatter KC, Harris AL "Invading edge vs inner" (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer. J Pathol. 2000 ; 192: 140-149.
13. Giatromanolaki A., Koukourakis MI, Kakolyris S., et al. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer. Clin Cancer Res. 1998 ; 4: 3017-3024.
14. Valkovic T., Dobrila F., Melato M., Sasso F., Rizzardi C., Jonjic N. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Virchows Arch. 2002 ; 440: 583-588.
15. Ito H., Oshita F., Kameda Y., et al. Expression of vascular endothelial growth factor and basic fibroblast growth factor in small adenocarcinomas. Oncol Rep. 2002 ; 9: 119-123.
16. Imoto H., Osaki T., Taga S., Ohgami A., Ichiyoshi Y., Yasumoto K. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma. J Thorac Cardiovasc Surg. 1998 ; 115: 1007-1014.
17. Sikora J., Slodkowska J., Radomyski A., et al. Immunohistochemical evaluation of tumour angiogenesis in adenocarcinoma and squamous cell carcinoma of lung. Rocz Akad Med Bialymst. 1997 ; 42 (suppl 1). 271-279.
18. Pezzella F., Pastorino U., Tagliabue E., et al. Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol. 1997 ; 151: 1417-1423.
19. Apolinario RM, van der Valk P., de Jong JS, et al. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. J Clin Oncol. 1997 ; 15: 2456-2466.
20. Koukourakis MI, Giatromanolaki A., Thorpe PE, et al. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. Cancer Res. 2000 ; 60: 3088-3095.
21. Inoshima N., Nakanishi Y., Minami T., et al. The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer. Clin Cancer Res. 2002 ; 8: 3480-3486.
22. Mineo TC, Ambrogi V., Baldi A., et al. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer. J Clin Pathol. 2004 ; 57: 591-597.
23. Yilmaz A., Ernam D., Unsal E., Demirag F., Atikcan S., Tastepe I. Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung cancer. Arch Med Res. 2007 ; 38: 764-768.
24. Liao M., Wang H., Lin Z., Feng J., Zhu D. Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer. Lung Cancer. 2001 ; 33: 125-132.
25. Baillie R., Carlile J., Pendleton N., Schor AM Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer. J Clin Pathol. 2001 ; 54: 116-120.
26. Yoo J., Jung JH, Lee MA, et al. Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis. J Korean Med Sci. 2007 ; 22: 318-325.
27. Singhal S., Vachani A., Antin-Ozerkis D., Kaiser LR, Albelda SM Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res. 2005 ; 11: 3974-3986.